News and Updates

Kalshi debuts prediction markets for clinical trials and FDA decisions, allowing traders to bet on biotech outcomes and evolving drug development news.

Experts argue that clinical trials are just the start. Learn why post-marketing surveillance is critical for long-term vaccine safety and efficacy.

Breakthroughs in blood-brain barrier technology are changing neurology. Learn how focused ultrasound and new drug delivery are transforming clinical trials.

Is Bayer stock a bargain after recent clinical trial partnerships? We analyze the firm’s pipeline strategy, R&D risks, and its path to long-term valuation.

New research suggests a common antidepressant may help treat chronic fatigue in Long COVID patients. Learn about the potential for symptom relief here.

Medicus Pharma is optimizing its Teverelix clinical trial design to boost efficiency and accelerate development. Learn about the strategic study updates.

Novo Nordisk introduces a lower-cost version of its semaglutide drug in South Africa following a court ruling against unauthorized weight-loss copies.

Natco Pharma receives tentative US FDA approval for Olaparib tablets. Learn how this PARP inhibitor milestone may impact future oncology treatment access.

GSK has halted development of the cough drug camlipixant after Phase 3 trials failed to meet primary efficacy goals. Get the full details on the clinical setback.

Arletta Pharma hits a key milestone for Lybrido, a novel treatment for HSDD. Discover how this FDA-backed therapy aims to transform female sexual health.